Aeolus Pharmaceuticals is a biopharmaceutical company focused on developing a platform of novel compounds in biodefense, oncology and pulmonary disorders. AOLS develops a class of catalytic antioxidant compounds that serve as medical countermeasures against nuclear, radiological, and chemical weapons and diseases and disorders of the respiratory system, central nervous system and oncology. Founded in 1994, the company is headquartered in Mission Viejo, California. For more information, visit the company’s website at www.aolsrx.com